The Alpha-1 Project has named Michael Iannotti to its postdoctoral fellowship position at the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS).
Iannotti was chosen after a 10-month interview process from among world-class candidates, says Jean-Marc Quach, director of The Alpha-1 Project (TAP), the venture philanthropy arm of the Alpha-1 Foundation. He will be trained in assay development, screening technology and data analysis under the direction of James Inglese, PhD, head of NCATS’ Assay Development and Screening Technology Laboratory, to focus on Alpha-1 treatment and become versed in how to lead translational research.
The Foundation is “thrilled by this excellent example of a public-private partnership working in close collaboration to cure Alpha-1,” says President John Walsh.
The steering committee — which includes lung and liver experts Bibek Gooptu, MD, Darryl Kotton, MD, Jeffrey Teckman, MD, Rick Sifers, MD, and Foundation Scientific Director Adam Wanner, MD — along with Quach and Inglese, will review Iannotti’s project progress every six months.
Iannotti, of Palm City, FL, is no stranger to Alpha-1; he was a Foundation post-doctoral research fellow from August 2013-March 2014, and has worked with Sifers, a top Alpha-1 researcher, at Baylor College of Medicine in Houston since 2010. But he came to it in a roundabout way. (Read in a 2004 Alpha-1-To-One magazine story how Sifers himself came to Alpha-1 circuitously.)